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Summary
A total of 1,000 barrows were used in a
98-day trial conducted in a commercial
research facility to determine the influence
of a direct fed microbial with and without
intermittent treatments of oxytetracycline
(OTC) at 400 g/ton. The direct fed microbial
was compared to a negative (no feed
antimicrobial) and positive control
(bacitracin methylene diasalicylate (BMD) at
30 g/ton, alternated with intermittent treat-
ments of OTC at 400 g/ton).  No significant
differences between the four treatments were
observed for any of the growth, efficiency, or
carcass parameters evaluated. These results
suggest that further work in quantifying the
effects of routinely utilizing in-feed anti-
microbials in the finishing period is war-
ranted.
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Introduction
Routine use of in-feed antimicrobials in
animal agriculture is currently being debated
as a public health issue.  This concern is due
to documented transmission of antimicrobial
resistant food-borne bacteria transmitted to
humans. Because reduced usage of anti-
microbials is known to reduce selection
pressure for antimicrobial resistance, reduc-
ing usage of in-feed antimicrobials should
lead to lower amounts of resistant bacteria,
and theoretically a lower incidence of anti-
microbial resistant food-borne bacteria trans-
mitted to humans.  Therefore, there has been
growing interest in identifying non-anti-
microbial alternatives for growth promotion
in swine.  The direct fed microbial used in
this study has shown promise for promoting
growth in poultry.  Direct fed microbials are
hypothesized to positively impact the bacte-
rial flora of the gastrointestinal tract by the
ongoing inoculation with microbes being
fed. Additionally, previous research has
indicated a greater growth rate response of
in-feed antimicrobials in commercial farms
compared to university research facilities.
Therefore, our objective was to evaluate the
effects of the direct fed microbial to finish-
ing pigs in a commercial research facility.  
Procedures
This experiment was conducted in a
commercial finishing research facility. Forty
pens (10 pens/treatment) of barrows (PIC
C22 × 337) were allotted to each treatment in
a randomized complete block design with an
average pig weight of 99.3 lb.  Pens had
totally slatted floors, were 10 × 18 ft, and
contained 25 pigs per pen.  Each pen was
equipped with a dry feeder (Staco, 50 inches
in length) and a cup waterer in this double
curtain sided, deep-pitted finishing barn. 
The four treatments consisted of a nega-
tive control, positive control, and feeding the
direct fed microbial product with and with-
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out intermittent treatments of OTC. The
negative controls (NEG) were not fed any
feed antimicrobials.  The positive controls
(POS) were fed BMD 30 g/ton alternated
with 3, 1-week doses of OTC at 400 g/ton
during weeks 1, 5, and 9 of the finishing
period.  The direct fed microbial (DFM)
product was fed continuously without any
antimicrobial pulses (DFM1) at a rate of 2
lb/ton during first two phases (8 weeks) of
the feeding period, and at 1 lb/ton for the last
two phases of the evaluation.  The direct fed
microbial product also was fed continuously
in conjunction with 3, 1-week intermittent
doses of 0TC at 400 g/ton (DFM2). These
four dietary treatments were fed in four
phases (Table 1).  The diets fed were corn-
soybean meal diets with 6% added fat, and 3
lb of synthetic lysine in all diets.  Dietary
energy, lysine, mineral, and vitamin content
were identical for all diets within each phase.
Diets were formulated to include 1.05%,
0.85%, 0.70%, and 0.60% total dietary
lysine, 0.62%, 0.61%, 0.52%, and 0.51%
calcium, and 0.58%, 0.56%, 0.47%, and
0.47% phosphorus for phases 1, 2, 3, and 4
respectively.
Pigs were weighed and pen weights were
obtained every 14 days. Feed delivery was
recorded daily for each pen, and feed re-
maining at the end of each phase was re-
moved from the feeder and weighed.  This
enabled feed intake and feed efficiency to be
determined for each pen. 
On day 84 of the trial, the four biggest
pigs were removed from each pen. The
weight of these pigs was used to calculate
the ADG, ADFI, and F/G for each pen.
However, the carcass data from these pigs
was not used in the carcass analysis.  The
remaining pigs were weighed off-test and
sold on day 98 of the trial.  All pigs in each
pen were identified with a unique tattoo and
maintained by pen integrity through the
packing plant.  Thus, mean carcass charac-
teristics were calculated for each pen.  At
slaughter, fat and loin depth were measured
with an optical probe to calculate percent
lean.  Fat, loin depth, and percent lean were
adjusted to a common carcass weight for
statistical evaluation. Data were analyzed
using GLM procedures of SAS in a random-
ized complete block design.
Results and Discussion
There were no significant differences
(P>0.10) between treatments for any of the
growth, intake, efficiency, or carcass param-
eters measured (Table 2). Performance im-
provements were not observed in pigs fed the
DFM or the antimicrobial regimens com-
pared to pigs fed the negative control diets
without an antimicrobial. 
It should be noted that this barn of pigs
was diagnosed with clinical salmonellosis
during phase 2 (d 29 to 56) of the experi-
ment.  Salmonella choleraesuis was isolated
from affected pigs at necropsy. The pigs
were orally vaccinated and recovered.  The
reduction in growth during phase 2 of this
trial associated with this disease episode is
evident.  It appears that neither the direct fed
microbial nor the antimicrobials being fed
influenced the outcome of this challenge.
Intensifying pressures to reduce or elimi-
nate the use of in-feed antimicrobials as
growth promoters will continue to drive the
need for the development of non-
antimicrobial growth promoters.  However,
the direct fed microbial product did not
demonstrate any impact on the growth or
carcass performance measured in this trial.
This trial also would suggest that further
work in quantifying the effects of routinely
utilizing in-feed antimicrobials in the finish-
ing period might be warranted.
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Table 1. Diet Feeding Regimen For Direct Fed Microbial Evaluation
Treatment
Item Negative Positive DFM1 DFM2
Phase 1
     Day 0 to 7 Negb PosOTCc DFMd DFM & PosOTCe
     Day 7 - 29 Neg PosBMDf DFM DFM
Phase 2
     Day 29-36 Neg PosOTC DFM DFM & PosOTC
     Day 36 to 56 Neg PosBMD DFM DFM
Phase 3
     Day 56 to 63 Neg PosOTC DFM DFM & PosOTC
     Day 63 to 84 Neg PosBMD DFM DFM
Phase 4
     Day 84 to 98 Neg BMD DFM DFM
aThree tons (24 lb/pig) of the OTC containing feed was fed at the beginning of Phase1, 2, and 3 for
the POS and DFM2 treatments.  This resulted in a 5 to 7 day dose of OTC containing diets being fed
at the beginning of the phase.  bNeg = No feed grade antibiotics or direct fed microbial.  cPosOTC =
Oxytetracyline at 400 g/ton.  dDFM= Direct fed microbial.  eDFM & PosOTC = Direct fed microbial
and Oxytetracyline at 400 g/ton.  fPosBMD = Bacitracin methylene diasalicylate (BMD) at 30 g/ton.
Table 2. Effects of a Direct Fed Microbial and Feed-Grade Antimicrobials on Growth,
Efficiency, and Carcass Performance
Treatment
Itema NEG POS DFM1 DFM2 SEM P-Value
Average Weights, lb
   Day 0 99.4 99.1 99.2 99.5 0.39 0.84
   Day 29 158.5 156.7 157 157.3 0.83 0.45
   Day 56 205.1 202.8 202.3 200.9 1.53 0.3
   Day 84 252.6 249.9 247.6 252.2 1.53 0.10
   Day 98 270.8 266.3 268.5 266.4 2.25 0.46
Phase I, 0 to 29
   ADG, lb 2.03 1.98 1.99 1.99 0.02 0.42
   ADFI, lb 4.45 4.45 4.45 4.45 0.11 0.99
   F/G 2.21 2.26 2.25 2.26 0.05 0.88
Phase II, d 29 to 56
   ADG, lb 1.70 1.66 1.62 1.59 0.05 0.45
   ADFI, lb 4.87 5.00 4.93 5.00 0.10 0.73
   F/G 2.87 3.01 3.07 3.19 0.09 0.12
Phase 3 & 4, d 56 to 98b
   ADG, lb 1.64 1.61 1.65 1.69 0.02 0.11
   ADFI, lb 5.54 5.37 5.40 5.38 0.09 0.54
   F/G 3.38 3.34 3.29 3.18 0.06 0.18
Total  (Day 0 - 98)
   ADG, lb 1.78 1.74 1.75 1.75 0.02 0.48
   ADFI, lb 5.02 4.98 4.98 5.00 0.08 0.98
   F/G 2.82 2.87 2.85 2.85 0.04 0.92
Carcass Data:
   % Yieldc 75.5 74.7 75.2 75.0 0.3 0.32
   Carcass wt, lbd 201.7 197 199.5 198.4 1.73 0.29
   Backfat, ind  0.76 0.75 0.75 0.76 0.01 0.97
   Loin depth, ind 2.15 2.17 2.17 2.14 0.02 0.61
   % Leand 53.6 53.8 53.8 53.6 0.2 0.84
aEach number is the mean of 10 pens (initially 25 barrows/pen).  bGrowth performance information
for phases 3 and 4 were combined due to the short duration of the phase 4 feeding period.  cYield
was calculated utilizing the live pen weights attained at the slaughter plant.  dBackfat, loin depth,
and percent lean were adjusted to a common carcass weight.
